Transcenta Announces the Appointment of Daniel Weng as CFO

SUZHOU, China, Dec. 16, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the...